Authors:
Raymond, E
Faivre, S
Weiss, G
McGill, J
Davidson, K
Izbicka, E
Kuhn, JG
Allred, C
Clark, GM
Von Hoff, DD
Citation: E. Raymond et al., Effects of hydroxyurea on extrachromosomal DNA in patients with advanced ovarian carcinomas, CLIN CANC R, 7(5), 2001, pp. 1171-1180
Authors:
Miller, CT
Weragoda, R
Izbicka, E
Iverson, BL
Citation: Ct. Miller et al., The synthesis and screening of 1,4,5,8-naphthalenetetracarboxylic diimide-peptide conjugates with antibacterial activity, BIO MED CH, 9(8), 2001, pp. 2015-2024
Authors:
Izbicka, E
Barnes, LD
Robinson, AK
Davidson, KK
Lawrence, RA
Hannibal, GT
Citation: E. Izbicka et al., Alterations in DNA repair and telomere maintenance mechanism affect response to porphyrins in yeast, ANTICANC R, 21(3B), 2001, pp. 1899-1903
Authors:
Rha, SY
Izbicka, E
Lawrence, R
Davidson, K
Sun, DK
Moyer, MP
Roodman, GD
Hurley, L
Von Hoff, D
Citation: Sy. Rha et al., Effect of telomere and telomerase interactive agents on human tumor and normal cell lines, CLIN CANC R, 6(3), 2000, pp. 987-993
Authors:
Tolcher, AW
Aylesworth, C
Rizzo, J
Izbicka, E
Campbell, E
Kuhn, J
Weiss, G
Von Hoff, DD
Rowinsky, EK
Citation: Aw. Tolcher et al., A phase I study of rhizoxin (NSC 332598) by 72-hour continuous intravenousinfusion in patients with advanced solid tumors, ANN ONCOL, 11(3), 2000, pp. 333-338
Authors:
Soda, H
Raymond, E
Sharma, S
Lawrence, R
Davidson, K
Oka, M
Kohno, S
Izbicka, E
Von Hoff, DD
Citation: H. Soda et al., Effects of androgens on telomerase activity in normal and malignant prostate cells in vitro, PROSTATE, 43(3), 2000, pp. 161-168
Authors:
Izbicka, E
Sommer, E
Skopinska-Rozewska, E
Davidson, K
Wu, RS
Orlowski, T
Pastewka, K
Citation: E. Izbicka et al., Tetracationic porphyrins inhibit angiogenesis induced by human tumor cellsin vivo, ANTICANC R, 20(5A), 2000, pp. 3205-3210
Authors:
Raymond, E
Soria, JC
Izbicka, E
Boussin, F
Hurley, L
Von Hoff, DD
Citation: E. Raymond et al., DNA G-quadruplexes, telomere-specific proteins and telomere-associated enzymes as potential targets for new anticancer drugs, INV NEW DR, 18(2), 2000, pp. 123-137
Authors:
Hidalgo, M
Izbicka, E
Eckhardt, SG
MacDonald, JR
Cerna, C
Gomez, L
Rowinsky, EK
Weitman, SD
Von Hoff, DD
Citation: M. Hidalgo et al., Antitumor activity of MGI 114 (6-hydroxymethylacylfulvene, HMAF), a semisynthetic derivative of illudin S, against adult and pediatric human tumor colony-forming units, ANTI-CANC D, 10(9), 1999, pp. 837-844
Authors:
Lawrence, RA
Izbicka, E
De Jager, RL
Tohgo, A
Clark, GM
Weitman, SD
Rowinsky, EK
Von Hoff, DD
Citation: Ra. Lawrence et al., Comparison of DX-8951f and topotecan effects on tumor colony formation from freshly explanted adult and pediatric human tumor cells, ANTI-CANC D, 10(7), 1999, pp. 655-661
Authors:
Hidalgo, M
Izbicka, E
Cerna, C
Gomez, L
Rowinsky, EK
Weitman, SD
Von Hoff, DD
Citation: M. Hidalgo et al., Comparative activity of the cyclopropylpyrroloindole compounds adozelesin,bizelesin and carzelesin in a human tumor colony-forming assay, ANTI-CANC D, 10(3), 1999, pp. 295-302
Authors:
Diab, SG
Hilsenbeck, SG
Izbicka, E
Weitman, SD
Von Hoff, DD
Citation: Sg. Diab et al., Significant activity of a novel cytotoxic agent, LY295501, against a wide range of tumors in the human tumor cloning system, ANTI-CANC D, 10(3), 1999, pp. 303-307
Authors:
Soda, H
Raymond, E
Sharma, S
Lawrence, R
Cerna, C
Gomez, L
Schaub, R
Von Hoff, DD
Izbicka, E
Citation: H. Soda et al., Recombinant human interleukin-11 is unlikely to stimulate the growth of the most common solid tumors, ANTI-CANC D, 10(1), 1999, pp. 97-101
Authors:
Petit, T
Izbicka, E
Lawrence, RA
Bishop, WR
Weitman, S
Von Hoff, DD
Citation: T. Petit et al., Activity of SCH 66336, a tricyclic farnesyltransferase inhibitor, against human tumor colony-forming units, ANN ONCOL, 10(4), 1999, pp. 449-453
Authors:
Dunstan, CR
Boyce, R
Boyce, BF
Garrett, IR
Izbicka, E
Burgess, WH
Mundy, GR
Citation: Cr. Dunstan et al., Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats, J BONE MIN, 14(6), 1999, pp. 953-959
Authors:
Britten, CD
Izbicka, E
Hilsenbeck, S
Lawrence, R
Davidson, K
Cerna, C
Gomez, L
Rowinsky, EK
Weitman, S
Von Hoff, DD
Citation: Cd. Britten et al., Activity of the multitargeted antifolate LY231514 in the human tumor cloning assay, CANC CHEMOT, 44(2), 1999, pp. 105-110
Authors:
Izbicka, E
Nishioka, D
Marcell, V
Raymond, E
Davidson, KK
Lawrence, RA
Wheelhouse, RT
Hurley, LH
Wu, RS
Von Hoff, DD
Citation: E. Izbicka et al., Telomere-interactive agents affect proliferation rates and induce chromosomal destabilization in sea urchin embryos, ANTI-CAN DR, 14(4), 1999, pp. 355-365
Authors:
Izbicka, E
Macdonald, JR
Davidson, K
Lawrence, RA
Gomez, L
Von Hoff, DD
Citation: E. Izbicka et al., 5,6 dihydro-5 '-azacytidine (DHAC) restores androgen responsiveness in androgen-insensitive prostate cancer cells, ANTICANC R, 19(2A), 1999, pp. 1285-1291
Authors:
Izbicka, E
Davidson, KK
Lawrence, RA
MacDonald, JR
Von Hoff, DD
Citation: E. Izbicka et al., 5,6-dihydro-5 '-azacytidine (DHAC) affects estrogen sensitivity in estrogen-refractory human breast carcinoma cell lines, ANTICANC R, 19(2A), 1999, pp. 1293-1298